Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94,179,674
-
Total 13F shares
-
50,481,358
-
Share change
-
+5,210,463
-
Total reported value
-
$941,464,132
-
Price per share
-
$18.65
-
Number of holders
-
106
-
Value change
-
+$94,025,834
-
Number of buys
-
58
-
Number of sells
-
44
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q2 2022
As of 30 Jun 2022 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) had 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 50,481,358 shares of stock of the company.
Largest 10 holders included DRIEHAUS CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., BVF INC/IL, ORBIMED ADVISORS LLC, FMR LLC, VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, WELLINGTON MANAGEMENT GROUP LLP, and STATE STREET CORP.
This table shows 106 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.